Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study
Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has bee...
Saved in:
Published in | Journal of inflammation research Vol. 15; pp. 2959 - 2969 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
31.05.2022
Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG).
From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI.
A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001).
Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI. |
---|---|
AbstractList | Background: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). Patients and Methods: From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count X neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 [less than or equal to]404.5, Q2 >404.5 and [less than or equal to]631.7, Q3 >631.7 and [less than or equal to]1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. Results: A total of the 46,333 patients (62.9 [+ or-]11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11,P = 0.771;Q3 group: OR: 1.04, 95% CI: 0.92-1.18,P = 0.553;Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). Conclusion: Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI. Keywords: systemic immune inflammation index, contrast-associated acute kidney injury, coronary angiography, preprocedural Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI. BackgroundInflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG). Patients and MethodsFrom January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤404.5, Q2 >404.5 and ≤631.7, Q3 >631.7 and ≤1082.8, Q4 >1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI. ResultsA total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87-1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92-1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45-1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan-Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001). ConclusionElevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI. Wenguang Lai,1,2,* Xiaoli Zhao,3,* Zhidong Huang,1,* Yun Xie,1,2,* Sijia Yu,1,4 Jiabin Tu,5 Dachuan Guo,6 Jiaming Xiu,5 Ziling Mai,1,2 Qiang Li,1 Haozhang Huang,1,4 Huanqiang Li,1 Jun-Yan Xu,1,7 Hongyu Lu,1 Guanzhong Chen,1 Shiqun Chen,1 Jin Liu,1 Yong Liu1 1Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China; 2School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People’s Republic of China; 3Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; 4The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People’s Republic of China; 5Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People’s Republic of China; 6Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 7Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, College of Emergency and Trauma, Hainan Medical University, Haikou, 571199, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yong Liu; Jin Liu, Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People’s Republic of China, Email liuyong@gdph.org.cn; ljaw397017568@163.comBackground: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune inflammation index (SII) has recently emerged as a new parameter for immune and inflammatory response evaluation. However, limited research has been undertaken to explore the relationship between SII and CA-AKI following coronary angiography (CAG).Patients and Methods: From January 2007 to December 2020, 46,333 patients undergoing CAG were included from 5 Chinese tertiary hospitals. SII was calculated as total peripheral platelets count × neutrophil-to-lymphocyte ratio. Patients were categorized by preprocedural SII quartiles: Q1 ≤ 404.5, Q2 > 404.5 and ≤ 631.7, Q3 > 631.7 and ≤ 1082.8, Q4 > 1082.8. Univariable and multivariable logistic regression were used to reveal the link between preprocedural SII and CA-AKI.Results: A total of the 46,333 patients (62.9 ± 11.5 years, female 28.1%) were included in the study. The incidence of CA-AKI was 8.4% in Q1 group, 8.7% in Q2 group, 9.4% in Q3 group, 15.1% in Q4 group. In the multivariable model, comparing the highest (Q4 group) to lowest (Q1 group) SII level categories, preprocedural SII was related to a higher risk of CA-AKI after fully adjusting for well-known confounders, and there was no statistically difference in the other two SII level categories (Q2 and Q3 groups) compared with Q1 group (adjusted model 3: Q2 group: OR: 0.98, 95% CI: 0.87– 1.11, P = 0.771; Q3 group: OR: 1.04, 95% CI: 0.92– 1.18, P = 0.553; Q4: OR: 1.65, 95% CI: 1.45– 1.88, p < 0.001; P for trend < 0.001). Similar results were found for all the subgroups analysis except for patients undergoing PCI, and the interaction analyses for age, PCI and AMI were significant. In addition, Kaplan–Meier curves demonstrated that the lowest quartile group showed the worst all-cause mortality in a significant SII level-dependent manner among the four groups (Log rank test; p < 0.0001).Conclusion: Elevated preprocedural SII level was a significant and independent risk factor for CA-AKI following CAG. Higher-quality prospective studies are needed to validate the predictive value of SII for CA-AKI.Keywords: systemic immune inflammation index, contrast-associated acute kidney injury, coronary angiography, preprocedural |
Audience | Academic |
Author | Xie, Yun Xiu, Jiaming Xu, Jun-Yan Lu, Hongyu Chen, Shiqun Liu, Jin Tu, Jiabin Li, Qiang Li, Huanqiang Huang, Zhidong Chen, Guanzhong Guo, Dachuan Mai, Ziling Huang, Haozhang Lai, Wenguang Yu, Sijia Zhao, Xiaoli Liu, Yong |
Author_xml | – sequence: 1 givenname: Wenguang surname: Lai fullname: Lai, Wenguang organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China – sequence: 2 givenname: Xiaoli surname: Zhao fullname: Zhao, Xiaoli organization: Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China – sequence: 3 givenname: Zhidong orcidid: 0000-0002-5267-5769 surname: Huang fullname: Huang, Zhidong organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 4 givenname: Yun surname: Xie fullname: Xie, Yun organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China – sequence: 5 givenname: Sijia surname: Yu fullname: Yu, Sijia organization: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China – sequence: 6 givenname: Jiabin surname: Tu fullname: Tu, Jiabin organization: Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People's Republic of China – sequence: 7 givenname: Dachuan surname: Guo fullname: Guo, Dachuan organization: Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China – sequence: 8 givenname: Jiaming surname: Xiu fullname: Xiu, Jiaming organization: Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, People's Republic of China – sequence: 9 givenname: Ziling surname: Mai fullname: Mai, Ziling organization: School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People's Republic of China – sequence: 10 givenname: Qiang surname: Li fullname: Li, Qiang organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 11 givenname: Haozhang surname: Huang fullname: Huang, Haozhang organization: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China – sequence: 12 givenname: Huanqiang surname: Li fullname: Li, Huanqiang organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 13 givenname: Jun-Yan surname: Xu fullname: Xu, Jun-Yan organization: Ministry of Education, Key Laboratory of Hainan Trauma and Disaster Rescue, College of Emergency and Trauma, Hainan Medical University, Haikou, 571199, People's Republic of China – sequence: 14 givenname: Hongyu surname: Lu fullname: Lu, Hongyu organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 15 givenname: Guanzhong surname: Chen fullname: Chen, Guanzhong organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 16 givenname: Shiqun surname: Chen fullname: Chen, Shiqun organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 17 givenname: Jin surname: Liu fullname: Liu, Jin organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China – sequence: 18 givenname: Yong surname: Liu fullname: Liu, Yong organization: Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35602662$$D View this record in MEDLINE/PubMed |
BookMark | eNptklFv0zAQxyM0xMbYE-_IEhJCQi124sTJHpCiaoNCEWiFZ8txLq2LYxfbKeoX4_Ph0DKtEvaDrfPv_ro7_58mZ8YaSJLnBE9TQtnbj_O76TIraEXyR8kFIaycMJyRswf38-TK-w0eF8M0pU-S8ywvcFoU6UXy-0bDTgRlDbId-upg66yEdnBCo-XeB-iVRPO-Hwyguem06PsDvYAd6BiSDoQHj8Ia0J3yP0aZmTXBCR8mtfdWKhGgRbUcAqBPqjWwj2mbwe3RrdXa_lJmFTOcNSKGarNSduXEdr2_RjX6POigJJgALjJr6wJahqHdP0sed0J7uDqel8n325tvsw-TxZf381m9mEha4HwiCwmE0bzpoKEYizyTtAPAUBHaprJJmxRIUzGW0a7psk5KRltJM8pIJYs8zy6T-UG3tWLDt071sUhuheJ_A9atuHCxQg08j0NtshxYy0rKoCyzqpKyErhsK0YpjlrvDlrboemhHbuKUz4RPX0xas1XdscrQgpKRoHXRwFnfw7gA--Vl6C1MGAHz-OPlimp8rSM6MsDuhKxNGU6GxXliPOaYUZZmqWj4PQ_VNzt-O3RaJ2K8ZOEVw8S1iB0WHurh9ER_hR8cwCls9476O7bJJiPxuXRuPxo3Ei_eDiZe_afTbM_yNHsGA |
CitedBy_id | crossref_primary_10_2147_JIR_S425189 crossref_primary_10_2147_CIA_S455588 crossref_primary_10_1371_journal_pone_0292646 crossref_primary_10_1002_clc_24219 |
Cites_doi | 10.1259/bjr.20130738 10.1016/j.lfs.2020.118379 10.1158/1078-0432.CCR-14-0442 10.2147/JIR.S334941 10.1016/j.hlc.2016.01.007 10.1080/00365513.2022.2034034 10.1016/j.ccl.2019.04.001 10.5527/wjn.v6.i3.86 10.1016/j.jacc.2016.05.099 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.jcin.2014.06.023 10.1016/j.jcin.2020.04.051 10.1161/CIRCULATIONAHA.112.103317 10.1038/nrneph.2014.180 10.1016/j.jacc.2004.06.068 10.1186/cc11228 10.1080/j.1600-0455.2003.00119.x 10.1007/s11239-020-02369-0 10.1111/eci.13230 10.3748/wjg.v23.i34.6261 10.1007/s40620-021-01021-1 10.1056/NEJMra1805256 10.1016/j.ebiom.2017.02.009 10.1016/j.ijcard.2015.04.242 10.1007/s11135-006-9018-6 10.1016/j.ijcard.2016.11.019 10.7150/jca.25691 10.1093/ndt/gfr807 10.1001/archinternmed.2011.1202 10.5301/jn.5000007 10.1080/14017431.2020.1846774 |
ContentType | Journal Article |
Copyright | 2022 Lai et al. COPYRIGHT 2022 Dove Medical Press Limited 2022 Lai et al. 2022 Lai et al. |
Copyright_xml | – notice: 2022 Lai et al. – notice: COPYRIGHT 2022 Dove Medical Press Limited – notice: 2022 Lai et al. 2022 Lai et al. |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.2147/JIR.S364915 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Lai et al |
EISSN | 1178-7031 |
EndPage | 2969 |
ExternalDocumentID | oai_doaj_org_article_5356b35e7d7847e88399cc9a08d97440 A707472320 10_2147_JIR_S364915 35602662 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 0YH 29K 2WC 53G 5VS 7RV 8FE 8FH 8FI 8FJ 8G5 ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI CCPQU D-I DIK DWQXO E3Z EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR IHW IPNFZ ITC KQ8 LK8 M2O M48 M7P M~E NAPCQ NPM OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TR2 UKHRP VDV AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c4605-c6ce1745bfeb400a53c4fee0e914d2cb2b2e1b97734fbf3fcc74dc434719c6553 |
IEDL.DBID | RPM |
ISSN | 1178-7031 |
IngestDate | Tue Oct 22 15:15:16 EDT 2024 Tue Sep 17 21:24:33 EDT 2024 Fri Aug 16 11:47:28 EDT 2024 Thu Feb 22 23:46:20 EST 2024 Tue Nov 12 23:20:44 EST 2024 Tue Aug 20 22:14:19 EDT 2024 Thu Sep 26 16:37:43 EDT 2024 Sat Sep 28 08:18:26 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | contrast-associated acute kidney injury preprocedural systemic immune inflammation index coronary angiography |
Language | English |
License | 2022 Lai et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4605-c6ce1745bfeb400a53c4fee0e914d2cb2b2e1b97734fbf3fcc74dc434719c6553 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work |
ORCID | 0000-0002-5267-5769 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116410/ |
PMID | 35602662 |
PQID | 2668219528 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5356b35e7d7847e88399cc9a08d97440 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9116410 proquest_miscellaneous_2668219528 gale_infotracmisc_A707472320 gale_infotracacademiconefile_A707472320 gale_healthsolutions_A707472320 crossref_primary_10_2147_JIR_S364915 pubmed_primary_35602662 |
PublicationCentury | 2000 |
PublicationDate | 20220531 |
PublicationDateYYYYMMDD | 2022-05-31 |
PublicationDate_xml | – month: 05 year: 2022 text: 20220531 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand |
PublicationTitle | Journal of inflammation research |
PublicationTitleAlternate | J Inflamm Res |
PublicationYear | 2022 |
Publisher | Dove Medical Press Limited Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Dove – name: Dove Medical Press |
References | Jang (ref6) 2015; 11 Machado (ref29) 2012; 27 Liu (ref30) 2021; 52 Mehran (ref13) 2004; 44 Chen (ref19) 2017; 23 Yang (ref8) 2018; 9 Lu (ref28) 2017; 17 Toso (ref25) 2014; 7 Zheng (ref9) 2021; 14 Ozkok (ref32) 2017; 6 Fuernau (ref23) 2015; 191 Laskey (ref27) 2003; 44 Liu (ref5) 2012; 25 Yang (ref10) 2020; 50 Kwasa (ref17) 2014; 87 Quintavalle (ref26) 2012; 126 Zhang (ref24) 2020; 259 Gok (ref20) 2021; 55 Esenboğa (ref21) 2022; 82 Mehran (ref16) 2019; 380 Hu (ref7) 2014; 20 O’Brien (ref15) 2007; 41 Amin (ref2) 2012; 172 Briguori (ref11) 2020; 13 Sato (ref3) 2017; 227 McCullough (ref4) 2016; 68 Kinsey (ref31) 2012; 16 Lun (ref1) 2021; 34 Kumar (ref22) 2019; 37 Kurtul (ref14) 2016; 25 Levey (ref12) 2009; 150 Tanık (ref18) 2019; 14 |
References_xml | – volume: 87 start-page: 20130738 year: 2014 ident: ref17 publication-title: Br J Radiol doi: 10.1259/bjr.20130738 contributor: fullname: Kwasa – volume: 14 start-page: 59 year: 2019 ident: ref18 publication-title: J Tehran Heart Cent contributor: fullname: Tanık – volume: 259 start-page: 118379 year: 2020 ident: ref24 publication-title: Life Sci doi: 10.1016/j.lfs.2020.118379 contributor: fullname: Zhang – volume: 20 start-page: 6212 year: 2014 ident: ref7 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-14-0442 contributor: fullname: Hu – volume: 14 start-page: 5769 year: 2021 ident: ref9 publication-title: J Inflamm Res doi: 10.2147/JIR.S334941 contributor: fullname: Zheng – volume: 25 start-page: 683 year: 2016 ident: ref14 publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2016.01.007 contributor: fullname: Kurtul – volume: 82 start-page: 132 year: 2022 ident: ref21 publication-title: Scand J Clin Lab Invest doi: 10.1080/00365513.2022.2034034 contributor: fullname: Esenboğa – volume: 37 start-page: 251 year: 2019 ident: ref22 publication-title: Cardiol Clin doi: 10.1016/j.ccl.2019.04.001 contributor: fullname: Kumar – volume: 6 start-page: 86 year: 2017 ident: ref32 publication-title: World J Nephrol doi: 10.5527/wjn.v6.i3.86 contributor: fullname: Ozkok – volume: 68 start-page: 1465 year: 2016 ident: ref4 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.05.099 contributor: fullname: McCullough – volume: 150 start-page: 604 year: 2009 ident: ref12 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 contributor: fullname: Levey – volume: 7 start-page: 1421 year: 2014 ident: ref25 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2014.06.023 contributor: fullname: Toso – volume: 13 start-page: 2065 year: 2020 ident: ref11 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2020.04.051 contributor: fullname: Briguori – volume: 126 start-page: 3008 year: 2012 ident: ref26 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.103317 contributor: fullname: Quintavalle – volume: 11 start-page: 88 year: 2015 ident: ref6 publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2014.180 contributor: fullname: Jang – volume: 44 start-page: 1393 year: 2004 ident: ref13 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2004.06.068 contributor: fullname: Mehran – volume: 16 start-page: 214 year: 2012 ident: ref31 publication-title: Crit Care doi: 10.1186/cc11228 contributor: fullname: Kinsey – volume: 44 start-page: 498 year: 2003 ident: ref27 publication-title: Acta Radiol doi: 10.1080/j.1600-0455.2003.00119.x contributor: fullname: Laskey – volume: 52 start-page: 440 year: 2021 ident: ref30 publication-title: J Thromb Thrombolysis doi: 10.1007/s11239-020-02369-0 contributor: fullname: Liu – volume: 50 start-page: e13230 year: 2020 ident: ref10 publication-title: Eur J Clin Invest doi: 10.1111/eci.13230 contributor: fullname: Yang – volume: 23 start-page: 6261 year: 2017 ident: ref19 publication-title: World J Gastroenterol doi: 10.3748/wjg.v23.i34.6261 contributor: fullname: Chen – volume: 34 start-page: 1479 year: 2021 ident: ref1 publication-title: J Nephrol doi: 10.1007/s40620-021-01021-1 contributor: fullname: Lun – volume: 380 start-page: 2146 year: 2019 ident: ref16 publication-title: N Engl J Med doi: 10.1056/NEJMra1805256 contributor: fullname: Mehran – volume: 17 start-page: 101 year: 2017 ident: ref28 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2017.02.009 contributor: fullname: Lu – volume: 191 start-page: 159 year: 2015 ident: ref23 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2015.04.242 contributor: fullname: Fuernau – volume: 41 start-page: 673 year: 2007 ident: ref15 publication-title: Qual Quant doi: 10.1007/s11135-006-9018-6 contributor: fullname: O’Brien – volume: 227 start-page: 424 year: 2017 ident: ref3 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.11.019 contributor: fullname: Sato – volume: 9 start-page: 3295 year: 2018 ident: ref8 publication-title: J Cancer doi: 10.7150/jca.25691 contributor: fullname: Yang – volume: 27 start-page: 3136 year: 2012 ident: ref29 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr807 contributor: fullname: Machado – volume: 172 start-page: 246 year: 2012 ident: ref2 publication-title: Arch Intern Med doi: 10.1001/archinternmed.2011.1202 contributor: fullname: Amin – volume: 25 start-page: 332 year: 2012 ident: ref5 publication-title: J Nephrol doi: 10.5301/jn.5000007 contributor: fullname: Liu – volume: 55 start-page: 91 year: 2021 ident: ref20 publication-title: Scand Cardiovasc J doi: 10.1080/14017431.2020.1846774 contributor: fullname: Gok |
SSID | ssj0000070424 |
Score | 2.3163617 |
Snippet | Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic immune... Background: Inflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic... BackgroundInflammation and immune responses play an important role in the pathophysiology of contrast-associated acute kidney injury (CA-AKI), and systemic... Wenguang Lai,1,2,* Xiaoli Zhao,3,* Zhidong Huang,1,* Yun Xie,1,2,* Sijia Yu,1,4 Jiabin Tu,5 Dachuan Guo,6 Jiaming Xiu,5 Ziling Mai,1,2 Qiang Li,1 Haozhang... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2959 |
SubjectTerms | Angiography Cardiac patients contrast-associated acute kidney injury coronary angiography Immune response Inflammation Original Research preprocedural Risk factors systemic immune inflammation index |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojyXFjBSJU6h2diOY24L6qpbHkKFSr1FsT1uAyiLNrtC_WP8Pmbi7CoRBy5c40kUeybzjeOZbxg7EoV1ynuF2xJjE6lTlZgUssRI4SzCvUhtlyD7KT-9kGeX6nLQ6otywiI9cFy4YyVUboUC7TU6UigQ0I1zpkoLb4jcrvO-qRlspmLgq-lML3ZWKRIiaY_FedSW5_hscf76i8iloWa4AzjqWPv_9s0DcBonTg6QaH6P3e1DSD6Lr77PbkFzn93-2B-SP2C_T35A_NHKl4F_JtpKBClP_Bo8EpTXji-oLgT4ogloErF8kX-gBCK8RIFkCy3H2JCf1-13egyxWK2qdp1s9Qmez9xmDfx97Ru4wdu-oXr4HO1q-QvxEO9YLanWl8-aq7onxn7DZ7wr-aWpwQplrjH855TMePOQXcxPvr47Tfr2DImjw9TE5Q5wP6NsAIueoFLCyQCQgplKn6GmbQZTi_GlkMEGEZzT0jspEA6Ny5USj9hes2zgCeNT7Z0GH1IogtSVscJnmQ6QZUGnlQgTdrTVUvkzsnCUuHshZZaozLJX5oS9JQ3uRIg6u7uABlX2BlX-y6Am7AXpv4x1qDsHUM409RrAABQlXnUS5AJw6V3VVzLgXIhMayR5OJLET9eNhl9ubaykIcp3a2C5aUsMmwrEEpUVE_Y42txuVvj-uHHOswnTI2scTXs80tTXHXM4Ilsup-nT_7FOB-xORqUgXSbFIdtbrzbwDAO0tX3efYt_AKnDORE priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIlW9IN4sFDBSJU4pWT_iBAmhBXXVlodQYaXeotgetwtVAsmuYP8Yv4-ZJLtqgBPXeBzJ-caemXjmG8b2ZWqd9l5jWJLZSJlYR1kMIsqUdBbNvYxtmyD7ITmaqZMzfbbF1s04-w_Y_DO0o35Ss_ry4Of31Svc8C8pjXmszPOT49ODTzJRGRWbXxMKQ3TK4ev9_M4PNnTF19Xn_Tlnl-1ITZ2YEjEwTi2H_98n9RVTNUyjvGKXpjfY9d6h5JNOA26yLShvsZ33_ZX5bfbr8BK63668CvwjkViiyfLEtsE7uvK548dUJQL8uAyoIF0xI39H6UT4iNzKBhqOniI_nTdf6TXEaVUXzSJaowueT9xyAfzt3JewwmlfECw-RS2rfqB1xBl1RZW_fFKez3ua7Bd8wtsCYFoa1ChzgThwSm1c3WGz6eHnN0dR36whcnS1GrnEAUY32gaweC4UWjoVAGLIxsoLxN0KGFv0NqUKNsjgnFHeKYnGMXOJ1vIu2y6rEu4zPjbeGfAhhjQoU2RWeiFMACGCiQsZRmx_jVL-rePkyDGWIVxzxDXvcR2x14TgRoSItNsHVX2e9_sy1wi9lRqMN2inIUV_MXMuK-LUZ8SdOGJPCP-8q0rdHAf5xFDnAXRHUeJZK0Eqip_eFX1dA66FqLUGknsDSdzIbjD8dK1jOQ1R9lsJ1bLJUTVTtCxapCN2r9O5zarWqjtiZqCNg2UPR8r5RcsjjnYuUeP4wX_PfMh2BVWDtMkUe2x7US_hEfpoC_u43X-_AcQRPxo priority: 102 providerName: Scholars Portal |
Title | Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35602662 https://search.proquest.com/docview/2668219528 https://pubmed.ncbi.nlm.nih.gov/PMC9116410 https://doaj.org/article/5356b35e7d7847e88399cc9a08d97440 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61RUJcEO8GSlikSpyc2N5dr80trRKaQqooUKk3y_tqDa1d5SHUP8bvY8aPKBY3Lj54Z6OsvxnPrHfmG0KOWay0MEbAtiRRHpe-8BLfhl7CmVbg7pmvqgTZi-jskp9fias9ItpamCppX6t8UNzeDYr8psqtvL_TwzZPbDifnYKBRjzwh_tkHxR0Z4tex7wSj_PqWjzswjM8ny4G31nEkwD71DCBXZeisOOIKr7-f9_KO26pmzK544Mmz8jTJniko_pPPid7tnhBHs-a4_GX5M_41tafWGnp6BwJK8E9GWTWoDU1ea7pFCtCLJ0WDpShLlyk3zB1CG5hCLmyKwpRIV3kq1_4M8hftcxWa69F0ho60pu1pV9zU9gHmPYTgKET0KjyN3hCmLEsscqXjorrvKHE_kxHtCr2xaXZJcjcQOBPMY3x4RW5nIx_nJ55TWMGT-MxqqcjbWEnI5SzCt4BmWCaO2t9mwTchICxCm2gILJk3CnHnNaSG80ZOMJER0Kw1-SgKAt7SGggjZbWON_GjsssUcyEoXQ2DJ30M-Z65LhFKb2v-TdS2Lcgringmja49sgJIrgVQdLs6ka5vE4b1UkFQK-YsNJI8Mk2htgw0TrJ_NgkyJPYIx8Q_7SuQN2afjqS2GUAQk-Q-FRJoPHDo9dZU8MAa0EarY7kUUcSjFZ3hj-2OpbiEGa6FbbcrFJQzRi8iAjjHnlT69x2Va3q9ojsaGNn2d0RMKGKM7wxmbf_PfMdeRJi5UeVOHFEDtbLjX0P8dha9cmjk_HFfNGvvmfA9ctVANcZj_uVZf4FdNo9EA |
link.rule.ids | 230,315,730,783,787,867,888,2109,24330,27936,27937,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s1CoUaqxCm72diOE25L1dVuu1tVpZV6s-JXG2iTah9C_WP8PmbyWG3EjWs8juJ8M5lxPPMNIQcs0UZYK2BbkuqAy1AEaeiiIOXMaHD3LNRVguxpPLnkx1fiaoeIthamSto3Ou8Xt3f9Ir-pcivv78ygzRMbnM0PwUBjPgwHj8hjsNeQb23S66hX4oFeXY2HfXgGx9Pz_g8W83SInWqYwL5LcdRxRRVj_7_f5S3H1E2a3PJC4xfkeRM-0lH9mC_JjitekSfz5oD8NflzdOvqn6y09PQMKSvBQVnk1qA1OXlu6BRrQhydFh7UoS5dpDNMHoJLGEQu3ZJCXEjP8-UvvA0yWC2y5SposXSWjsx65ehJbgv3ANN-AjR0DDpV_gZfCDMWJdb50lFxnTek2N_oiFblvrg0twCZGwj9KSYyPrwhl-Oji8NJ0LRmCAwepAYmNg72MkJ7p-ErkAlmuHcudOmQ2whQ1pEbaogtGffaM2-M5NZwBq4wNbEQ7C3ZLcrCvSd0KK2RzvrQJZ7LLNXMRpH0Loq8DDPme-SgRUnd1wwcCnYuiKsCXFWDa498RwQ3IkibXV0oF9eqUR4lAHrNhJNWgld2CUSHqTFpFiY2RabEHtlH_FVdg7oxfjWS2GcAgk-Q-FpJoPnDqzdZU8UAa0EirY7kXkcSzNZ0hr-0OqZwCHPdCleulwpUMwE_IqKkR97VOrdZVau6PSI72thZdncEjKhiDW-M5sN_z9wnTycX85maTU9PPpJnEdaBVGkUe2R3tVi7TxCdrfTnyhb_AgGNPAw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBa2Dih2GfZutm7VgAI7uXEsybJ3y7oGTV8IuhXozbAkqvXW2kEeGPrH9vtG2k4QY7ddLcqw8pEiFZEfGdsXibHKOYXHktQEUocqSEOIglQKa9Ddi9DUCbIX8fGVPLlW1xutvuqkfWuKg_Lu_qAsbuvcyum97a_yxPqT80M00FgOwv7U-f5j9gRtNow3DupN5KvpUq-pyKNePP2T8eXBdxHLdEDdaoSi3ktx1HFHNWv_v3vzhnPqJk5ueKLRc_asDSH5sPnUF-wRlC_Z9nl7Sf6K_Tm6g-aPVl55PiHaSnRSjvg1eENQXlg-proQ4OPSo0o05Yv8jBKI8BEFknOYc4wN-WUx_0WvIRarWT5fBCs8wfGhXS6AnxauhAec9hPh4SPUq-o3-kOcMauo1pcPy5uiJcb-woe8LvmlpcEMZW4x_OeUzPjwml2Njn4cHgdte4bA0mVqYGMLeJ5RxoPBnSBXwkoPEEI6kC5CpE0EA4PxpZDeeOGt1dJZKdAdpjZWSrxhW2VVwg7jA-2sBudDSLzUeWqEiyLtIYq8DnPhe2x_hVI2bVg4Mjy9EK4Z4pq1uPbYV0JwLULU2fWDanaTtQqUKYTeCAXaafTMkGCEmFqb5mHiUmJL7LE9wj9r6lDXG0A21NRrAANQlPhcS9AWgD-9zdtKBlwLkWl1JHc7kmi6tjP8aaVjGQ1RvlsJ1XKeoWom6EtUlPTY20bn1qtaqW6P6Y42dpbdHUFDqpnDW8N5998z99j25NsoOxtfnL5nTyMqBakzKXbZ1mK2hA8YoC3Mx9oU_wJlqz0f |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevation+of+Preprocedural+Systemic+Immune+Inflammation+Level+Increases+the+Risk+of+Contrast-Associated+Acute+Kidney+Injury+Following+Coronary+Angiography%3A+A+Multicenter+Cohort+Study&rft.jtitle=Journal+of+inflammation+research&rft.au=Lai%2C+Wenguang&rft.au=Zhao%2C+Xiaoli&rft.au=Huang%2C+Zhidong&rft.au=Xie%2C+Yun&rft.date=2022-05-31&rft.pub=Dove&rft.eissn=1178-7031&rft.volume=15&rft.spage=2959&rft.epage=2969&rft_id=info:doi/10.2147%2FJIR.S364915&rft_id=info%3Apmid%2F35602662&rft.externalDBID=PMC9116410 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7031&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7031&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7031&client=summon |